Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
May 11, 2026
May 11, 2026
NEW YORK, May 11 -- Rockefeller University posted the following news:
* * *
Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
*
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego the traditional daily dose of antiretroviral drugs. In one recent clinical study of bNAbs identified and developed into therapies at Rockefeller Universi . . .
* * *
Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
*
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego the traditional daily dose of antiretroviral drugs. In one recent clinical study of bNAbs identified and developed into therapies at Rockefeller Universi . . .